ClinCalc Pro
Menu
Non-Depolarising Neuromuscular Blocking Agent Pregnancy: Compatible for anaesthetic maintenance — minimal transplacental transfer

Atracurium

Brand names: Tracrium

Adult dose

Dose: Intubation: 0.4–0.5 mg/kg IV. Maintenance: 0.1–0.2 mg/kg supplementary doses. ICU infusion: 5–10 mcg/kg/min.
Route: IV
Frequency: Bolus or continuous infusion
Max: Supplementary doses every 15–25 min
Hofmann elimination — metabolism independent of renal/hepatic function. Produces laudanosine (metabolite) in high doses — may cause seizures in ICU patients with organ failure. Histamine release possible at high doses.

Paediatric dose

Dose: 0.3 mg/kg
Route: IV
Frequency: Supplementary 0.1–0.2 mg/kg every 15–25 min
Max: 0.5 mg/kg
Concentration: 10 mg/mL mg/ml
Neonates and infants: same dose. Cisatracurium preferred in ICU for lower laudanosine production.

Dose adjustments

Renal

No dose adjustment required (Hofmann elimination)

Hepatic

No dose adjustment required (Hofmann elimination)

Paediatric weight-based calculator

Neonates and infants: same dose. Cisatracurium preferred in ICU for lower laudanosine production.

Clinical pearls

  • Organ-independent Hofmann elimination: ideal in hepatorenal failure or when reliable metabolism needed
  • Preferred over vecuronium in liver disease as less hepatic dependency
  • Cisatracurium (stereoisomer) preferred for long-term ICU infusion — less histamine release and less laudanosine
  • Store at 2–8°C — do not freeze; decompose at room temperature over time

Contraindications

  • Hypersensitivity to atracurium

Side effects

  • Histamine release (flushing, bronchospasm, hypotension)
  • Laudanosine accumulation (ICU — theoretical seizure risk)
  • Anaphylaxis (rare)
  • Muscle weakness post-use

Interactions

  • Aminoglycosides — prolonged neuromuscular blockade
  • Volatile anaesthetics — enhanced blockade
  • Suxamethonium — do not mix
  • Calcium channel blockers — enhanced blockade

Monitoring

  • Train-of-four (TOF) neuromuscular monitoring
  • Respiratory function when reversing
  • Blood pressure during histamine-releasing doses

Reference: BNFc; BNF; Miller's Anaesthesia; BETTS Study Group. Verify against your local formulary and the latest BNF before prescribing.

Related

Curated clinical cross-links plus same-class fallbacks.